Abemaciclib + Endocrine Therapy Improves Survival in HR-Positive, HER2-Negative Early Breast Cancer
15.8 percent lower risk for death seen with abemaciclib-ET versus ET in intent-to-treat population
Enzalutamide + Leuprolide Boosts Overall Survival for Prostate Cancer With High Recurrence Risk
Enzalutamide monotherapy was not superior to leuprolide alone
Sentinel Lymph Node Biopsy Noninferior to Lymphadenectomy in Cervical Cancer
Sentinel lymph node biopsy alone noninferior with respect to disease-free survival, linked to fewer complications
Loneliness, Social Isolation Tied to Higher Mortality in Patients With Cancer
Findings seen for both cancer-specific and all-cause mortality
Recurrence-Free Survival Longer With Nivolumab Than Ipilimumab in Melanoma
Median duration of recurrence-free survival was 61.1 months with nivolumab and 24.2 months with ipilimumab
Niraparib Plus AAP Improves Survival in mCSPC With HRR Gene Alterations
Significant improvement in radiographic progression-free survival seen first in BRCA subgroup
New $1.3B Lawsuit Accuses Johnson & Johnson of Hiding Baby Powder Cancer Risk
The case marks the first group claim against the company in the United Kingdom
Incidence Rates Increased From 2003 to 2017 for Six Cancer Types in 42 Countries
Apart from colorectal cancer, increases in incidence were seen in both younger and older adults
CHEST: SGLT2 Inhibitors May Slow Nodule Growth in Pulmonary Malignancies
Patients prescribed SGLT2 inhibitors less likely to exhibit nodule growth and to undergo a surgical intervention
FDA to Fast-Track 9 Experimental Drugs Under New Trump Program
The drugs include potential new treatments for vaping addiction, deafness, pancreatic cancer and other serious health conditions
